Trestle Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Trestle Biotherapeutics's estimated annual revenue is currently $542.5k per year.
- Trestle Biotherapeutics's estimated revenue per employee is $77,500
Employee Data
- Trestle Biotherapeutics has 7 Employees.
- Trestle Biotherapeutics grew their employee count by 0% last year.
Trestle Biotherapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder & CEO | Reveal Email/Phone |
2 | Co-Founder & CSO | Reveal Email/Phone |
3 | Principal Scientist | Reveal Email/Phone |
4 | Executive Chairman | Reveal Email/Phone |
Trestle Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Trestle Biotherapeutics?
Trestle Biotherapeutics, Inc. is a preclinical stage company developing bioengineered therapies for patients living with end stage renal disease. Once implanted, these bioengineered stem cell-derived tissues will get patients off dialysis, delay their need for transplantation, and one day become replacement organs.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$542.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 7 | 0% | $6.1M |
#2 | $3.5M | 7 | -30% | N/A |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.9M | 7 | N/A | N/A |
#5 | $0.5M | 7 | N/A | N/A |